AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

HIV Policy & Programs

FDA Commissioner Margaret A. Hamburg’s statement on FDA’s blood donor deferral policy for men who have sex with men

FDA

The U.S. Food and Drug Administration is a science-based regulatory agency that works to protect and promote the public health. In this role, it is our responsibility to regulate the blood supply and to help ensure its continued safety for the patients who receive these life-saving products. Over the past several years, in collaboration with…

Douglas Brooks: World AIDS Day & New Year’s Reflection

Listen:

Javascript and flash are required to play this audio file.

Download MP3
Douglas Brooks

As 2014 draws to a close, we sat down with Douglas Brooks, Director of the White House Office of National AIDS Policy (ONAP), to talk about his reflections on the White House’s World AIDS Day 2014 event and his thoughts about the work ahead in 2015 to move closer to an AIDS-free generation. In his review…

FDA approves Viekira Pak to treat hepatitis C

FDA

The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis. Hepatitis C is a viral disease that causes inflammation of the liver that…

Black Voices: HIV from a Friend’s Perspective

Anthony Roberts, Jr.

As an HIV-negative, black, gay male, I can’t pretend to know the feelings and emotions that come with discovering that you are HIV-positive. However, what I do know is that I have chosen to use my skills in marketing and communications to inform, influence, advocate, and serve as an ally for individuals near and far…

Two New Hepatitis C Resources Support Expanding Provider Capacity

Ronald Valdiserri

Two professional medical societies have recently launched initiatives to support a wider variety of health care providers in adapting to new roles and opportunities resulting from the rapidly evolving arena of hepatitis C (HCV) screening, diagnosis, and treatment. As the Viral Hepatitis Action Plan observes, providers at every level in the healthcare system can play…

The 2014 Liver Meeting – Report on Viral Hepatitis Coverage at the American Association for the Study of Liver Diseases (AASLD) Meeting

Capture

Last month, the American Association for the Study of Liver Diseases (AASLD) annual meeting  (The Liver Meeting®) took place, convening nearly 10,000 physicians, surgeons, researchers, allied health professionals and advocates from around the world to discuss the natural history, prevention, and cure of liver diseases. With the availability of new all-oral, direct-acting agents (DAAs), there…

Blog Digest: Your one-stop reading about World AIDS Day 2014

World AIDS Day logo

This month, many individuals and organizations in the HIV community were exceptionally busy organizing, attending, and communicating about local, state, regional, national, and international events in observance of World AIDS Day 2014. In case you missed any of our posts leading up to World AIDS Day, we offer a list below (in reverse order). We…

New Recommendations on Treatment and Prevention in Persons with HIV

Recommendations for HIV prevention with adults and adolescents l

Last week, the Centers for Disease Control and Prevention (CDC), in collaboration with the U.S. Health Resources and Services Administration, the National Institutes of Health, and five non-governmental CDC partner organizations,* published a new guideline, Recommendations for HIV Prevention with Adults and Adolescents with HIV in the United States, 2014. This document is a comprehensive…